Navigation Links
Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
Date:6/11/2009

Copenhagen, Denmark, Thursday 11 June 2009: Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study presented today presented today at PReS 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism (EULAR) in Copenhagen, Denmark.

Effective treatment options are available to treat rhematic diseases, many of which have the potential to induce remission, defined as absence of signs or symptoms of disease. While there is evidence-based advice regarding when to initiate therapy in rheumatic diseases, there is no specific guidance on the timing of treatment withdrawal once a state of remission on medication is achieved. While this holds true for many autoimmune disease (such as Rheumatoid Arthritis, Crohn's disease, Ulcerative Colitis, or Autoimmune Hepatitis), in the case of MTX therapy for JIA, a continuation of MTX for 12 to 24 months after induction of remission has been proposed by researchers.1

The risk of relapse in JIA patients, once MTX is discontinued, is approximately 50%.2 However, the results of this study have shown that continuing MTX therapy past the point of remission does not affect the risk of relapses after withdrawal of therapy. Clinical (disease subtype, duration or dosage of therapy, duration of MTX therapy) or standard laboratory tests (c-reactive protein and erythrocyte sedimentation rate as measurements of inflammation) could not differentiate between patients at-risk for relapse and those without this risk. However, MRP8/14 levels were significantly higher at MTX withdrawal in remission in those patients who subsequently developed relapses (715140 ng/ml) compared to patients with stable remission (400105 ng/ml; p=0.003).

Levels of MRP8/14 were especially high in p
'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-078-943-86425
European League Against Rheumatism
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel biomarkers in heart failure
2. Biomarkers May Help Measure Rate of Decline in Dementia
3. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
4. BioTech Firm Decodes Current Swine Flu BioMarkers
5. Biomarkers May Predict Aggressiveness of Prostate Cancer
6. Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease
7. Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
8. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
9. Biomarkers detected for Chikungunya fever
10. New genomic markers associated with risk of heart disease and early heart attack
11. Biochemical markers for non-invasive assessment of primary biliary cirrhosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:3/28/2015)... Virginia (PRWEB) March 28, 2015 ARDX will ... 28th from 12pm -3pm at the Chesapeake Conference Center in ... by sponsoring an empowering event for women in the Hampton ... Weaving the Stories of Women’s Lives. Women grow stronger ... from each other. This year the WWC™ theme is ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... from dating experts Samantha Sanderson and Jason Rogers has ... buzz of media attention. The commotion surrounding the course's ... prompting him to publish an in-depth review of the ... when the men in their lives suddenly start pulling ...
(Date:3/27/2015)... York, New York (PRWEB) March 27, 2015 ... ( http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases ... diabetes has granted Pfizer Inc.’s Motion to Dismiss four ... According to a Case Management Order issued in the ... 23rd, the Court determined that the dismissals were warranted ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Healthpointe ... Stanley G. Katz, M.D., is now treating knee and ... including Anaheim , Long Beach, and La Mirada. ... of acute knee and hip joint disorders as well ... Katz is passionate in returning his patients back to ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3
... BMR, TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Bradmer ... development and,commercialization of cancer therapies, today announced its ... Operational Highlights, During the three months ended ... date, the Company achieved the following milestones related ...
... November 10, 2008 Ewing sarcoma is the second ... children and young adults. Patients with relapsed or refractory ... Cytarabine decreases the levels of a certain key protein ... against Ewing sarcoma cell lines in the laboratory. Treatment ...
... 10 PARI Pharma GmbH has,successfully completed Phase ... PARI Tobramycin 100 (150mg/1.5mL) formulation delivered via a,customized ... with the PARI LC PLUS jet nebulizer. While ... difference was,a reduction in the average inhalation time ...
... the American,Diabetes Association there are 23.6 million children ... and approximately one million people are,diagnosed with the ... in the U.S. resulted in $116 billion in ... epidemic, Health Management Corporation,(HMC), a nationally recognized leader ...
... access, distrust of docs behind inequalities in treatment , , ... appropriate care and distrust of doctors are among the ... say. , Allergists were expected to discuss these issues ... the American Academy of Allergy, Asthma & Immunology (ACAAI) ...
... Services Partners,Inc. (OTC Bulletin Board: TTSPU) announced today ... Krishna as a director at its board meeting,held ... an experienced,health care entrepreneur, having started several companies. ... which assists U.S.,pharmaceutical companies perform Phase II clinical ...
Cached Medicine News:Health News:Bradmer announces 2008 third quarter operational and financial results 2Health News:Bradmer announces 2008 third quarter operational and financial results 3Health News:Bradmer announces 2008 third quarter operational and financial results 4Health News:Bradmer announces 2008 third quarter operational and financial results 5Health News:Bradmer announces 2008 third quarter operational and financial results 6Health News:Bradmer announces 2008 third quarter operational and financial results 7Health News:Bradmer announces 2008 third quarter operational and financial results 8Health News:Bradmer announces 2008 third quarter operational and financial results 9Health News:Bradmer announces 2008 third quarter operational and financial results 10Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 2Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 3Health News:PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF 4Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 2Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 3Health News:Barriers to Good Asthma Care Detailed 2
(Date:3/27/2015)... , March 27, 2015 A new report ... Latin America – Chile , ... are top targets for IVD firms.  The healthcare research ... heavily into IVD strategies for the Latin American continent with ... support globally distributed supply operations. However, the country,s regional economic ...
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... trauma patients. Available in both small (6mm) ... External Fixation System from Zimmer is a modular system that ... The XtraFix System allows surgeons to eliminate steps, ... process, resulting in saved time, costs and overall team effort. ...
(Date:3/27/2015)... -- CHINA AID, the 10 ... Medicine and Healthcare, second to none in ... at Shanghai New International Expo Center on 22-24 April. ... on Encouraging Private Capital to Participate in the Development ... by the Ministry of Civil Affairs of the ...
Breaking Medicine Technology:Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... Dec. 11 As Warner Chilcott plc (Nasdaq: ... global branded prescription pharmaceuticals business of The Procter & ... Acquisition"), constituted a change of control under a global ... P&G subsidiary acquired by Warner Chilcott and Sanofi-Aventis U.S. ...
... , IRVINE, Calif., Dec. 11 PRO-DEX, INC. (Nasdaq: ... Annual Shareholders Meeting held on December 4, 2009. At the ... Healey, David Holder and Mark Murphy as directors; (ii) approved the ... split if it should elect to do so at any time ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: